This inventor holds 1 USPTO granted patent. Top assignees: Forschungsverbund Berlin E.v., Universität Zu Koln. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 93 
1 out of 28 
Years Active: 2025
Title: Innovations by Inventor Stephan Dohmen
Introduction
Stephan Dohmen is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of chemical compounds, particularly in the development of structural mimetics of proline-rich peptides. His work has implications for pharmaceutical applications, especially in the treatment of tumor diseases.
Latest Patents
One of his key patents is titled "Polyproline mimetics of proline-derived module-15." This invention relates to chemical compounds that can selectively inhibit Ena/VASP-EVH1-mediated protein-protein interactions. The compounds developed by Dohmen are not only innovative but also hold potential as pharmaceutical agents for treating various tumor diseases.
Career Highlights
Stephan Dohmen has worked with prestigious institutions such as Universität zu Köln and Forschungsverbund Berlin e.V. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Throughout his career, Dohmen has collaborated with notable colleagues, including Matthias Barone and Ronald Kühne. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
Stephan Dohmen's innovative work in the field of chemical compounds showcases his dedication to advancing pharmaceutical science. His contributions, particularly in the development of proline mimetics, highlight the importance of research in addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile